Lung Association of Nova Scotia

The Lung Association of Nova Scotia’s mission is to improve the quality of life by controlling and preventing lung disease through research, advocacy, patient services and education. The Lung Association of Nova Scotia works on chronic disease, infectious disease, tobacco related issues and environmental issues.

During 2015, GSK funded the Lung Association of Nova Scotia with $25,000 in corporate funding.

GSK’s contributions to the Lung Association of Nova Scotia represent 2.5% of the organization’s total revenue in 2015.

< Back to Links